SEC Form 4 · accession 0001019687-15-003610
International Stem Cell CORP · ISCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul V Maier
Director
Period of report
Sep 30, 2015
Accepted (ET)
Oct 2, 2015 · 11:04 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355790
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 30, 2015 | A | 2,011 | $0.00 | A | 6,621 | D | |
| Common StockF2 | holding | — | — | — | 1,360 | I | Through Family Trust Dated 4/21/2000 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Common Stock granted as part of compensation for non-employee directors, with vesting at the time of grant.
- F2On July 29, 2015 the Issuer effected a 150-for-1 reverse stock split, with fractional shares being rounded up to the next whole share. Shares reported as being beneficially owned in this Form 4 have been adjusted for the reverse stock split. Future reports on Form 4 or Form 5 will reflect the result of the reverse stock split on securities that were outstanding on July 29, 2015.